> CPDR News
AACR 2007 Highlights
CPDR Presentations 2007 AACR Annual Meeting, held in Los Angeles, California, April 14-18, 2007
May 25, 2007
The Center for Prostate Disease Research was represented by six outstanding presentations at the 2007 from the Basic Science Research programs lead by Dr. Shiv Srivastava, Professor and Co-Director Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences (USU).
Annual Meeting of American Association for Cancer Research is one of the largest meeting for Cancer research. The theme of the 2007 annual meeting was "A Century of Leadership in Science - A Future of Cancer Prevention and Cures," commemorated the AACR's Centennial and underscored the remarkable scientific advances that researchers have achieved in the 100 years since the organization's founding, as well as the critical importance of ongoing research. The meeting was attended a group of more than 16,000 scientists, representing more than 70 countries.
Presentations by the CPDR team included:
Quantitative features of a common TMPRSS2-ERG fusion transcript in prostate cancer was highlighted by Dr Dobi et al and Petrovics et al. ERG, has been shown as the most frequent oncogenic alteration in prostate cancer
The highlights of CPDR presentations include: exciting findings on the function and regulation of PMEPA1 in prostate cancer, which is one of the androgen regulated gene presented by Dr. Hongyun Li et al.
Dr Shaeduzzaman et al presented a potential for Anti-cancer cell growth effects of lactotransferrin (LTF) gene in prostate cancer.
Dr. Hongzhen Li et al, presented the isolation and characterization of pluripotent stem cells derived from telomerase immortalizedprostate cell lines. The conference was a great success for the benefit of Basic researchers in the field of Prostate cancer.
Evaluation of New Prostate Cancer Specific Secretory Protein Panel in Serum of Prostate Cancer Patients was highlighted by Dr Kee-Hong Kim. He has highlighted that the prostate cancer specific secretory protein panel as defined by the integrative prostate cancer genomics, knowledge based protein informatics and targeted experimental approaches have potential to provide highly promising biomarker candidates in serum for more precise prostate cancer diagnosis.
The CPDR mission is fulfilled primarily through its three principal programs – the Clinical Research Center, the Basic Science Research Program and the National Multicenter Prostate Cancer Database– and through a robust education and training program that operates out of its Headquarters location, the Clinical Research Center, and the original laboratories at USUHS. CPDR is also committed to patient outreach, primarily through its affiliation with the WRAMC US TOO! organization and through a heavy schedule of health fairs in which it participates.
